Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
suNR1se II: CC-101 in Chronic Ischemic Stroke
NCT07709845Phase 2Not yet recruiting
- Sponsor
- Clarion Cells
- Start
- Jan 2027
- Primary completion
- Jan 2029
01
Overview
A Phase 2 trial of CC-101 in ischemic stroke, sponsored by Clarion Cells. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
CC-101
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07709845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07709845.